Fortis Life Sciences

Fortis Life Sciences is a rapidly growing, integrated life science tools and services company formed in 2021. It combines a portfolio of off-the-shelf reagents with a comprehensive suite of contract development and manufacturing (CDMO/CRO) services, targeting the diagnostics, biopharma, and spatial biology markets. The company's strategy leverages vertical integration and domestic US manufacturing to ensure supply chain reliability and scalability for its clients. Its business model is built on being a full-service partner, from early-stage R&D through commercial-scale production.

Integrated service and manufacturing infrastructure for immunoreagent development, antibody conjugation, VHH discovery, viral vector production (AAV/adenovirus), nanoparticle synthesis, and spatial biology services.

Fortis competes with large diversified players like Thermo Fisher Scientific and Danaher, pure-play reagent suppliers like Abcam, and a fragmented landscape of CDMOs and CROs. Its differentiation lies in combining vertical integration of key reagents with a broad service portfolio under one roof.